From research to diagnosis to treatment, AI has the potential to improve outcomes for some treatments by 30 to 40 percent and reduce costs by up to 50 percent. Obtaining the large data sets necessary for generalizability, transparency, and reducing bias has historically been difficult and time-consuming. That’s why the University of California, San Francisco (UCSF) collaborated with Microsoft, Fortanix, and Intel to create BeeKeeperAI.